NPRA Banner

               
Product Search   QUEST3+ System   Enquiries   Sitemap  

Thanks for Joining #MedSafetyWeek 2023 💖

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

 

 

As #MedSafetyWeek draws to a close,

the safety of medicines and patients everywhere remains a top priority.
 Lovers 

😵 If you suspect you’re experiencing a side effect from a medicine,

✅remember to submit a report to NPRA ADR/AEFI Reporting System (👉 as a healthcare professional or 👉 a consumer) and get treated if necessary.

📝 By submitting detailed reports, you can help us improve #PatientSafety and make medicines safer for all! 

 

TQ-Card-3

 

 

#MedSafetyWeek hampir berakhir,

namun keselamatan ubat dan pesakit di seluruh dunia tetap menjadi keutamaan kami.

 

card-selamat

  😵 Jika anda mengesyaki anda sedang mendapat kesan sampingan disebabkan ubat-ubatan,

✅ sila laporkan melalui Sistem Pelaporan ADR/AEFI NPRA (👉 sebagai anggota kesihatan atau 👉 sebagai pengguna) dan mendapatkan rawatan sekiranya perlu. 

 

 📝 Dengan menghantar laporan yang lengkap dan terperinci, dapat memberikan kami maklumat penting bagi memastikan ubat-ubatan selamat untuk digunakan.

  

Terima kasih kerana menyertai #MedSafetyWeek 2023 💖

 

Card-4-Carousel-Intro


#ReportSideEffects ✅ #NPRA #laporkesansampingan #ConSERF

 

 

 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Site Last Modified

  • Last Modified: Wednesday 02 October 2024, 21:12:35.

Search

Main Menu English